Ekso Bionics Reports Second Quarter 2025 Financial Results

Stock Information for Mersana Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Mersana Therapeutics Inc.

Ekso Bionics Inks Agreement to Become the Exclusive U.S. Distributor of MediTouch's Groundbreaking BalanceTutor(TM) Rehabilitation System
Ekso Bionics Announces $3.7 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules
Ekso Bionics Reports Third Quarter 2025 Financial Results
Ekso Bionics to Report Second Quarter 2025 Financial Results on July 28 - Conference Call to Follow
Virtual eksoUniversity to Support Continuing Education of PTs and PTAs Across the Country
Ekso Bionics' Acceptance into NVIDIA Connect Program Bears Early Fruit
Ekso Bionics Announces New Effective Date of Reverse Stock Split
Ekso Bionics Announces Reverse Stock Split

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.